Mitoxantrone-preloaded water-responsive phospholipid-amorphous calcium carbonate hybrid nanoparticles for targeted and effective cancer therapy

BACKGROUND: The application of mitoxantrone (MIT) in cancer therapy has been severely limited by its inherent drawbacks. In addition, effective cancer therapy calls for drug release systems capable of enforcing drug release within cancer cells in response to infinite stimulant with enhanced drug pen...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Cheng, Han, Min, Liu, Xuerong, Chen, Shaoqing, Hu, Fuqiang, Sun, Jihong, Yuan, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396884/
https://www.ncbi.nlm.nih.gov/pubmed/30880961
http://dx.doi.org/10.2147/IJN.S193976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396884/
https://www.ncbi.nlm.nih.gov/pubmed/30880961
http://dx.doi.org/10.2147/IJN.S193976

Ejemplares similares